# Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

> **NCT05697913** · NA · UNKNOWN · sponsor: **Hospital Galdakao-Usansolo** · enrollment: 66 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Continued treatment adapted to the response

## Key facts

- **NCT ID:** NCT05697913
- **Lead sponsor:** Hospital Galdakao-Usansolo
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05697913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05697913, "Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05697913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*